XJPX3671
Market cap32mUSD
Jan 09, Last price
855.00JPY
1D
0.12%
1Q
-0.70%
Jan 2017
-34.83%
IPO
-80.59%
Name
Softmax Co Ltd
Chart & Performance
P/E
11.35
P/S
0.98
EPS
75.35
Div Yield, %
3.49%
Shrs. gr., 5y
—
Rev. gr., 5y
7.48%
Revenues
5.26b
+4.15%
Net income
452m
+7.78%
CFO
232m
+29.08%
Dividend
Dec 27, 202430 JPY/sh
Profile
Softmax Co., Ltd develops, sales, introduction, and maintenance of corporate systems. It is also involved in medical information system development. The company also offers web based electronic medical record system, web based ordering system, medical accounting, radiology information, rehabilitation department system, health check-up system, nursing work management system, and surgical department system. Softmax Co., Ltd was incorporated in 1974 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||
Revenues | 5,260,000 4.15% | 5,050,266 12.50% | |||
Cost of revenue | 4,668,000 | 4,513,980 | |||
Unusual Expense (Income) | |||||
NOPBT | 592,000 | 536,286 | |||
NOPBT Margin | 11.25% | 10.62% | |||
Operating Taxes | 173,000 | 175,731 | |||
Tax Rate | 29.22% | 32.77% | |||
NOPAT | 419,000 | 360,555 | |||
Net income | 452,000 7.78% | 419,387 -0.75% | |||
Dividends | (179,000) | (118,000) | |||
Dividend yield | 4.00% | 2.16% | |||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | 1,169,000 | 1,170,436 | |||
Long-term debt | 166,000 | 191,870 | |||
Deferred revenue | |||||
Other long-term liabilities | 491,000 | 464,060 | |||
Net debt | (2,188,000) | (2,058,664) | |||
| Cash flow | |||||
Cash from operating activities | 232,000 | 179,730 | |||
CAPEX | (17,000) | (15,934) | |||
Cash from investing activities | (11,000) | (4,747) | |||
Cash from financing activities | (200,041) | (144,933) | |||
FCF | 104,592 | 292,473 | |||
| Balance | |||||
Cash | 2,922,000 | 2,851,233 | |||
Long term investments | 601,000 | 569,737 | |||
Excess cash | 3,260,000 | 3,168,457 | |||
Stockholders' equity | 2,916,000 | 2,645,645 | |||
Invested Capital | 2,126,000 | 1,997,861 | |||
ROIC | 20.32% | 18.67% | |||
ROCE | 11.74% | 11.55% | |||
| EV | |||||
Common stock shares outstanding | 5,995 | 5,980 | |||
Price | 746.00 -18.38% | 914.00 13.12% | |||
Market cap | 4,471,929 -18.18% | 5,465,277 13.40% | |||
EV | 2,283,929 | 3,406,613 | |||
EBITDA | 620,000 | 560,547 | |||
EV/EBITDA | 3.68 | 6.08 | |||
Interest | 4,709 | ||||
Interest/NOPBT | 0.88% | ||||